tm
Seeing Is Believing
tm
Seeing Is Believing
DAWN is currently covered by 6 analysts with an average price target of $22.89. This is a potential upside of $9.13 (6.32%) from yesterday's end of day stock price of $21.53.
Day One Biopharmaceuticals's activity chart (see below) currently has 98 price targets and 86 ratings on display. The stock rating distribution of DAWN is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 8.26% with an average time for these price targets to be met of 33.37 days.
Highest price target for DAWN is $34, Lowest price target is $21.5, average price target is $22.89.
Most recent stock forecast was given by from JPMORGAN on 11-Mar-2026.
Currently out of the existing stock ratings of DAWN, 13 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-Jun-2021
$21.5
$-0.03 (-0.14%)
$27
3 months 28 days ago
(11-Mar-2026)
1/7 (14.29%)
$0.25 (1.18%)
42
Buy Since 15-Dec-2022
$21.5
$-0.03 (-0.14%)
$22
3 months 29 days ago
(10-Mar-2026)
1/17 (5.88%)
$0.22 (1.03%)
43
Buy Since 21-Jun-2021
$21.5
$-0.03 (-0.14%)
$30
4 months ago
(09-Mar-2026)
1/10 (10%)
$0.17 (0.80%)
44
Buy Since 27-Feb-2024
$21.5
$-0.03 (-0.14%)
$20
4 months 3 days ago
(06-Mar-2026)
2/6 (33.33%)
$0.3 (1.42%)
80
Buy Since 14-Dec-2022
$17
4 months 3 days ago
(06-Mar-2026)
3/20 (15%)
$6.07 (55.54%)
108
What is DAWN (Day One Biopharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on DAWN (Day One Biopharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on DAWN (Day One Biopharmaceuticals)?
Which analyst is the currently most bullish on DAWN (Day One Biopharmaceuticals)?
Which analyst is the currently most reserved on DAWN (Day One Biopharmaceuticals)?
